A carregar...
Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses
Immunotherapies in tumors have attracted increasing attention. They play an important role in precision medicine. Many immune-checkpoint inhibitors (ICIs) have obtained FDA approval and show good performance in the clinic. Hyperprogressive disease (HPD) after ICIs was first described in November 201...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201048/ https://ncbi.nlm.nih.gov/pubmed/32411591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00515 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|